This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2012 May;32(5):769-70.

doi: 10.1038/jcbfm.2012.17. Epub 2012 Feb 29.

The search for sensitive biomarkers in presymptomatic Huntington disease

Pierre-Gilles Henry¹, Fanny Mochel

Affiliations

Affiliation

¹ Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota Medical School, 2021 6th Street SE, Minneapolis, MN 55455, USA. henry@cmrr.umn.edu

PMID: 22373644
PMCID: PMC3345907
DOI: 10.1038/jcbfm.2012.17

Review

The search for sensitive biomarkers in presymptomatic Huntington disease

Pierre-Gilles Henry et al. J Cereb Blood Flow Metab. 2012 May.

. 2012 May;32(5):769-70.

doi: 10.1038/jcbfm.2012.17. Epub 2012 Feb 29.

Authors

Pierre-Gilles Henry¹, Fanny Mochel

Affiliation

¹ Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota Medical School, 2021 6th Street SE, Minneapolis, MN 55455, USA. henry@cmrr.umn.edu

PMID: 22373644
PMCID: PMC3345907
DOI: 10.1038/jcbfm.2012.17

No abstract available

PubMed Disclaimer

Similar articles

pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.
Chaumeil MM, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Levi AC, Carlier P, Lebon V. Chaumeil MM, et al. J Cereb Blood Flow Metab. 2012 May;32(5):771-9. doi: 10.1038/jcbfm.2012.15. Epub 2012 Feb 29. J Cereb Blood Flow Metab. 2012. PMID: 22373643 Free PMC article.
Key role of nuclear medicine in seeking biomarkers of Huntington's disease.
Squitieri F, Ciarmiello A. Squitieri F, et al. Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1124-7. doi: 10.1007/s00259-010-1439-8. Eur J Nucl Med Mol Imaging. 2010. PMID: 20358195 No abstract available.
Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease.
Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, Mackay AL, Leavitt BR. Sturrock A, et al. Neurology. 2010 Nov 9;75(19):1702-10. doi: 10.1212/WNL.0b013e3181fc27e4. Neurology. 2010. PMID: 21060093 Free PMC article.
Diagnostic problems in Huntington's chorea and tardive dyskinesia.
Buxton M. Buxton M. Compr Psychiatry. 1976 Mar-Apr;17(2):325-33. doi: 10.1016/0010-440x(76)90007-9. Compr Psychiatry. 1976. PMID: 130224 Review. No abstract available.
Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease.
Lee WT, Chang C. Lee WT, et al. Prog Neurobiol. 2004 Feb;72(2):87-110. doi: 10.1016/j.pneurobio.2004.02.002. Prog Neurobiol. 2004. PMID: 15063527 Review.

See all similar articles

Cited by

Neurochemical correlates of caudate atrophy in Huntington's disease.
Padowski JM, Weaver KE, Richards TL, Laurino MY, Samii A, Aylward EH, Conley KE. Padowski JM, et al. Mov Disord. 2014 Mar;29(3):327-35. doi: 10.1002/mds.25801. Epub 2014 Jan 17. Mov Disord. 2014. PMID: 24442623 Free PMC article.
Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases.
Gomez-Casati DF, Zanor MI, Busi MV. Gomez-Casati DF, et al. Biomed Res Int. 2013;2013:792527. doi: 10.1155/2013/792527. Epub 2013 Aug 6. Biomed Res Int. 2013. PMID: 23986911 Free PMC article. Review.
Laser Evoked Potentials in Early and Presymptomatic Huntington's Disease.
de Tommaso M, Franco G, Ricci K, Montemurno A, Sciruicchio V. de Tommaso M, et al. Behav Neurol. 2016;2016:8613729. doi: 10.1155/2016/8613729. Epub 2016 Mar 21. Behav Neurol. 2016. PMID: 27087746 Free PMC article.
EEG Functional Connectivity and Cognitive Variables in Premanifest and Manifest Huntington's Disease: EEG Low-Resolution Brain Electromagnetic Tomography (LORETA) Study.
Delussi M, Nazzaro V, Ricci K, de Tommaso M. Delussi M, et al. Front Physiol. 2020 Dec 17;11:612325. doi: 10.3389/fphys.2020.612325. eCollection 2020. Front Physiol. 2020. PMID: 33391027 Free PMC article.

References

1. Chaumeil M, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Levy A-C, Carlier P, Lebon V.2012pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study J Cereb Blood Flow Metab(this issue) - PMC - PubMed
1. Mochel F, Haller RG. Energy deficit in Huntington disease: why it matters. J Clin Invest. 2011;121:493–499. - PMC - PubMed
1. Novak MJ, Tabrizi SJ. Huntington's disease. BMJ. 2010;340:c3109. - PubMed
1. Paulsen JS, Wang C, Duff K, Barker R, Nance M, Beglinger L, Moser D, Williams JK, Simpson S, Langbehn D, van Kammen DP. Challenges assessing clinical endpoints in early Huntington disease. Mov Disord. 2010;25:2595–2603. - PMC - PubMed
1. Roze E, Saudou F, Caboche J. Pathophysiology of Huntington's disease: from Huntingtin functions to potential treatments. Curr Opin Neurol. 2008;21:497–503. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information